12 Einträge gefunden

1. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

   1. Dimopoulos, Meletios A
   2. Merlini, Giampaolo
   3. Bridoux, Frank
   4. Leung, Nelson
   5. Mikhael, Joseph
   6. Harrison, Simon J
   7. Kastritis, Efstathios

   2023 - Forschungsinformationssystem des UKE
2. Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial

   1. Weisel, Katja
   2. Dimopoulos, Meletios A
   3. San-Miguel, Jesús
   4. Paner, Agne
   5. Engelhardt, Monika
   6. Taylor, Fiona
   7. Lord-Bessen, Jennifer

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
3. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

   1. Dimopoulos, Meletios A
   2. Richardson, Paul G
   3. Bahlis, Nizar J
   4. Grosicki, Sebastian
   5. Cavo, Michele
   6. Beksaç, Meral
   7. Legieć, Wojciech

   2022 - Forschungsinformationssystem des UKE
4. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

   1. Dimopoulos, Meletios A
   2. Jakubowiak, Andrzej J
   3. McCarthy, Philip L
   4. Orlowski, Robert Z
   5. Attal, Michel
   6. Bladé, Joan
   7. Goldschmidt, Hartmut

   2020 - Forschungsinformationssystem des UKE
5. Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis

   1. Dimopoulos, Meletios A
   2. Niesvizky, Ruben
   3. Weisel, Katja
   4. Siegel, David S
   5. Hajek, Roman
   6. Mateos, María-Victoria
   7. Cavo, Michele

   2020 - Forschungsinformationssystem des UKE
6. Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

   1. Dimopoulos, Meletios A
   2. Lonial, Sagar
   3. White, Darrell
   4. Moreau, Philippe
   5. Weisel, Katja
   6. San-Miguel, Jesus
   7. Shpilberg, Ofer

   2020 - Forschungsinformationssystem des UKE
7. Early M-protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma

   1. Yan, Xiaoyu
   2. Xu, Xu Steven
   3. Weisel, Katja C
   4. Mateos, Maria-Victoria
   5. Sonneveld, Pieter
   6. Dimopoulos, Meletios A
   7. Usmani, Saad Zafar

   2020 - Forschungsinformationssystem des UKE
8. Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma

   1. Goldschmidt, Hartmut
   2. Dimopoulos, Meletios A
   3. Rajkumar, S Vincent
   4. Weisel, Katja C
   5. Moreau, Philippe
   6. Chng, Wee-Joo
   7. Mikala, Gábor

   2020 - Forschungsinformationssystem des UKE
9. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease

   1. Terpos, Evangelos
   2. Morgan, Gareth
   3. Dimopoulos, Meletios A
   4. Drake, Matthew T
   5. Lentzsch, Suzanne
   6. Raje, Noopur
   7. Sezer, Orhan

   2013 - Forschungsinformationssystem des UKE
10. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

    1. Palumbo, Antonio
    2. Bringhen, Sara
    3. Ludwig, Heinz
    4. Dimopoulos, Meletios A
    5. Bladé, Joan
    6. Mateos, Maria V
    7. Rosiñol, Laura

    2011 - Forschungsinformationssystem des UKE
11. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

    1. Cavo, Michele
    2. Rajkumar, S Vincent
    3. Palumbo, Antonio
    4. Moreau, Philippe
    5. Orlowski, Robert
    6. Bladé, Joan
    7. Sezer, Orhan

    2011 - Forschungsinformationssystem des UKE
12. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.

    1. Dimopoulos, Meletios A
    2. Terpos, Evangelos
    3. Chanan-Khan, Asher
    4. Leung, Nelson
    5. Ludwig, Heinz
    6. Jagannath, Sundar
    7. Niesvizky, Ruben

    2010 - Forschungsinformationssystem des UKE